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Abstract
Background: The secretion time course of Bacillus anthracis strain RA3R (pXO1+/pXO2-) during early, mid, and
late log phase were investigated under conditions that simulate those encountered in the host. All of the identified
proteins were analyzed by different software algorithms to characterize their predicted mode of secretion and
cellular localization. In addition, immunogenic proteins were identified using sera from humans with cutaneous
anthrax.
Results: A total of 275 extracellular proteins were identified by a combination of LC MS/MS and MALDI-TOF
MS. All of the identified proteins were analyzed by SignalP, SecretomeP, PSORT, LipoP, TMHMM, and PROSITE
to characterize their predicted mode of secretion, cellular localization, and protein domains. Fifty-three proteins
were predicted by SignalP to harbor the cleavable N-terminal signal peptides and were therefore secreted via the
classical Sec pathway. Twenty-three proteins were predicted by SecretomeP for secretion by the alternative Sec
pathway characterized by the lack of typical export signal. In contrast to SignalP and SecretomeP predictions,
PSORT predicted 171 extracellular proteins, 7 cell wall-associated proteins, and 6 cytoplasmic proteins.
Moreover, 51 proteins were predicted by LipoP to contain putative Sec signal peptides (38 have SpI sites),
lipoprotein signal peptides (13 have SpII sites), and N-terminal membrane helices (9 have transmembrane helices).
The TMHMM algorithm predicted 25 membrane-associated proteins with one to ten transmembrane helices.
Immunogenic proteins were also identified using sera from patients who have recovered from anthrax. The
charge variants (83 and 63 kDa) of protective antigen (PA) were the most immunodominant secreted antigens,
followed by charge variants of enolase and transketolase.
Conclusion: This is the first description of the time course of protein secretion for the pathogen Bacillus
anthracis. Time course studies of protein secretion and accumulation may be relevant in elucidation of the
progression of pathogenicity, identification of therapeutics and diagnostic markers, and vaccine development. This
study also adds to the continuously growing list of identified Bacillus anthracis secretome proteins.
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Background
Bacillus anthracis is a Gram-positive spore-forming bacte-
rium that is the etiologic agent of anthrax [1]. During the
course of infection, the virulent spores germinate to
become vegetative cells. The bacterium secretes two major
virulence factors, the bipartite edema and lethal toxins
that are encoded by plasmid pXO1 [1-3]. The common
component of both toxins is the protective antigen (PA)
which is not toxic by itself. PA binds a specific receptor on
the host cells and translocates the edema factor (EF) and
lethal factor (LF) inside the cells where they exert their
damaging action. Transcription of the genes coding for
these virulence factors has been shown to be coordinately
induced by bicarbonate-CO2. High CO2  tension is
believed to simulate conditions encountered within the
host [4]. In addition, the effect of temperature has been
shown to be important for toxin production but not for
production of antiphagocytic capsule, whose synthesis is
encoded by genes on plasmid pXO2 [5]. Thus, when B.
anthracis is cultured at 37°C in a bicarbonate-containing
minimal medium, toxin production is enhanced.
The composition and identification of B. anthracis extra-
cellular proteins (secretome) has been the subject of
recent proteomic studies [6-9]. In B. cereus, a close relative
of B. anthracis, most of these secreted proteins include col-
lagenases, phospholipases, hemolysins, proteases, and
enterotoxins that are positively regulated by plcR  [10].
However, a non-sense mutation inactivates a homolog of
this gene in B. anthracis resulting in a significant reduction
of these secreted proteins [1,11,12]. Using 2-DE and
MALDI-TOF MS, Chitlaru et al. [6] have identified 64
extracellular proteins in a virulent B. anthracis strain, of
which 50 exhibit export signal peptides. Thirty-one of
these secreted proteins harbor features that are character-
istic of virulence determinants suggesting that in addition
to the "classic" lethal and edema toxins, a large number of
proteins may be essential for B. anthracis virulence [6].
Additionally, in minimal medium under high CO2 ten-
sion, the presence of the plasmids led to the enhanced
secretion of 12 chromosome-encoded and 5 pXO1
encoded proteins. Ten of the chromosome-encoded pro-
teins could not be detected in the absence of the plasmids.
These results suggest distinct plasmid and chromosome
CO2-dependent crosstalk mechanisms that modulate
extracellular proteolytic activities. Likewise, Antelmann et
al. [7] have identified 64 extracellular proteins in the non-
virulent B. anthracis strain UM23C1-2 (pXO1-/pXO2-), 29
of which were predicted to be secreted. The remainder of
the extracellular proteins were predicted to be associated
with the cell wall or the cytosol. Based on the nature of B.
anthracis secretome, it was suggested that this organism is
adapted to life in a protein-rich environment due to the
presence of a variety of proteases, peptidases, peptide-
binding proteins, as well as enzymes required for the
metabolism of amino acids. It was also proposed that
these secreted proteases and peptidases could be useful
targets for the development of improved vaccines.
In another study, Gohar et al. [8] compared the fully cured
B. anthracis extracellular proteomes to two other members
of the B. cereus group, B. cereus and B. thuringiensis, that
were also cured of their plasmids. The secretomes of the
three species included both cell wall and cytosolic pro-
teins that are similar in all three species. However,
whereas the extracellular proteins of B. cereus and B. thur-
ingiensis contained a large number of secreted proteins
such as degradative enzymes and toxins, those of B.
anthracis contained only one secreted protein, a metallo-
protease InhA1. These results are in contrast to those
reported by Chitlaru et al. [6] and Antelmann et al. [7]
where 31 and 29 secreted proteins were identified in the
culture filtrate of fully cured B. anthracis cells, respectively.
Using minimal medium under high CO2 tension, a com-
parative analysis of the extracellular proteomes of three
isogenic strains of B. anthracis that differed solely in their
plasmid content was conducted by Lamonica et al. [9]. In
this study, the use of SignalP for the prediction of cellular
function and location of each protein indicated that most
of the identified proteins were either cell wall-associated
or cytoplasmic in the fully cured strain, RA3:00.
The present study characterized the time course of protein
secretion and accumulation in the culture of B. anthracis
strain RA3R (pXO1+/pXO2-). Secretion patterns at the dif-
ferent time points are due not only to differentially
expressed proteins at various phases of exponential
growth, but also to the accumulation of proteins in the
culture and their stability therein. Particular focus was
placed on the analysis of protein secretion during the
exponential growth phase to preclude the identification of
proteins that may have been caused by bacterial lysis. In
addition, computer assisted comparative analysis using
2D Phoretix of the cytosol with the secretome at16 hr
under induced conditions was performed. LC MS/MS was
used as a complementary tool in identifying proteins that
were not amenable to MALDI-TOF MS, significantly
increasing the number of identified secreted proteins. The
data from this analysis add to the growing list of identified
proteins in the secretome database of B. anthracis and help
in further identifying key pathways associated with viru-
lence. Furthermore, immunogenic proteins, or the immu-
nome, of the secretome were identified using sera from
human patients infected with cutaneous anthrax. Identifi-
cation of these immunodominant antigens is essential for
development of more efficacious and safer vaccines
against anthrax.Proteome Science 2007, 5:11 http://www.proteomesci.com/content/5/1/11
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Results
Time course of protein secretion
The extracellular proteomes of B. anthracis strain RA3R
were analyzed at three time points during the exponential
growth phase, i.e., early (6 hr), mid (10 hr) and late log
(16 hr) under induced, host-simulated conditions (Fig.
1). 2D Phoretix computer-assisted analysis of 2-DE aver-
age gels revealed that the number of protein spots
increased from 54 spots at 6 hr to 308 spots at 10 hr and
to 536 spots at 16 hr. (Figs. 2A–C). In contrast, the
number of protein spots at 16 hr under uninduced condi-
tion (Fig. 3) is only 178 or 33% of the total number under
induced condition (Fig. 4). The S-layer proteins Sap (sur-
face array protein) and EA1 (extractable antigen 1), PA,
and enolase were the predominant proteins that increased
in secretion (Fig. 5). Other highly expressed proteins
include alkyl hydroperoxide reductase, chaperonin
60kDa, phosphoglycerate isomerase, sulfatase, manga-
nese superoxide dismutase, and a zinc-binding lipopro-
tein.
Extracellular proteins
A total of 275 proteins were identified in the extracellular
proteome by a combination of MALDI-TOF MS and LC
MS/MS (Fig. 3/4, additional file 1). MALDI-TOF MS anal-
ysis has identified 52 proteins of which 47 were also iden-
tified by LC MS/MS analysis. In contrast, 270 proteins
were identified by LC MS/MS. This indicates that the com-
bined use of MALDI-TOF MS and LC MS/MS has signifi-
cantly increased the total number of identified proteins in
the extracellular proteome, which has also been observed
in the analysis of the proteome of other bacteria such as
Mycobacterium tuberculosis [13] and Brucella abortus [14].
2-DE gel images of SYPRO Ruby-stained secretome proteins  of toxigenic, non-encapsulated B. anthracis strain RA3R  (pXO1+/pXO2-) from pH 4 to 7 at 6 hr (A), 10 hr (B) and 16  hr (C) after inoculation under conditions that simulate those  found inside the host (induced), and (D) Western blot analy- sis of immunogenic extracellular proteins at 16 hr using sera  from patients infected with cutaneous anthrax Figure 2
2-DE gel images of SYPRO Ruby-stained secretome proteins 
of toxigenic, non-encapsulated B. anthracis strain RA3R 
(pXO1+/pXO2-) from pH 4 to 7 at 6 hr (A), 10 hr (B) and 16 
hr (C) after inoculation under conditions that simulate those 
found inside the host (induced), and (D) Western blot analy-
sis of immunogenic extracellular proteins at 16 hr using sera 
from patients infected with cutaneous anthrax. Spot numbers 
refer to additional file 1.
Growth curve for B. anthracis strain RA3R (pXO1+/pXO2-)  in R medium under host simulated conditions (induced) Figure 1
Growth curve for B. anthracis strain RA3R (pXO1+/pXO2-) 
in R medium under host simulated conditions (induced). 
Secretome proteins were harvested at time points 6, 10, and 
16 hrs as indicated by the arrows.Proteome Science 2007, 5:11 http://www.proteomesci.com/content/5/1/11
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The B. anthracis secretome proteins were also grouped into
major cellular functions (Fig. 6). Half of all identified
secretome proteins are involved in energy metabolism
(17.8%), protein synthesis (10.9%), cellular structure
(8.7%), or are hypothetical (13%). This distribution is sig-
nificantly different from role category predictions of all
genes theoretically encoded by B. anthracis. Some groups
were overrepresented or underrepresented relative to the
theoretical total B. anthracis proteome, where energy
metabolism accounts for 5.2%, protein synthesis is 2.4%,
cellular structure is 7.1%, and hypothetical proteins are
40.6% of all cellular proteins. The role category predic-
tions of B. anthracis were obtained from The Institute for
Genomic Research website [15].
Some of the secretome proteins have metabolic functions
that would typically place them in the cytoplasm. How-
ever, 2-DE secretome and cytosol subproteomes show dis-
tinct, significantly different patterns from another (Fig. 7).
Using MALDI-TOF MS the protein spots in the cytosol
were identified, the relative protein spot intensities ana-
lyzed, and their ratio to each other determined. These
results were used for computer assisted comparison of
cytosol and secretome 2-DE gels. Out of the 489 unique
Relative protein expression of differentially expressed extra- cellular proteins of B. anthracis strain RA3R (pXO1+/pXO2-)  during exponential growth at 6 hr (green bars), 10 hr (red  bars) and 16 hr (yellow bars), based on spot size and pixel  intensity Figure 5
Relative protein expression of differentially expressed extra-
cellular proteins of B. anthracis strain RA3R (pXO1+/pXO2-) 
during exponential growth at 6 hr (green bars), 10 hr (red 
bars) and 16 hr (yellow bars), based on spot size and pixel 
intensity. The relative amount of each protein was deter-
mined using the 2D Phoretix software. The protein numbers 
refer to additional file 1.
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Role category pie chart showing the percentage of all identi- fied B. anthracis strain RA3R (pXO1+/pXO2-) secretome pro- teins in each role family Figure 6
Role category pie chart showing the percentage of all identi-
fied B. anthracis strain RA3R (pXO1+/pXO2-) secretome pro-
teins in each role family.
Annotated 2-DE gel image of SYPRO Ruby-stained secre- tome proteins of B. anthracis strain RA3R (pXO1+/pXO2-) at  16 hr after inoculation under laboratory conditions (unin- duced) Figure 3
Annotated 2-DE gel image of SYPRO Ruby-stained secre-
tome proteins of B. anthracis strain RA3R (pXO1+/pXO2-) at 
16 hr after inoculation under laboratory conditions (unin-
duced). Spot numbers refer to additional file 1.
Annotated 2-DE gel image of SYPRO Ruby-stained secre- tome proteins of B. anthracis strain RA3R (pXO1+/pXO2-) at  16 hr after inoculation under host simulated conditions  (induced) Figure 4
Annotated 2-DE gel image of SYPRO Ruby-stained secre-
tome proteins of B. anthracis strain RA3R (pXO1+/pXO2-) at 
16 hr after inoculation under host simulated conditions 
(induced). Spot numbers refer to additional file 1.Proteome Science 2007, 5:11 http://www.proteomesci.com/content/5/1/11
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protein spots in the cytosol, 56 are more than two-fold up
regulated, 84 are more than two-fold down regulated, and
177 proteins spots have no corresponding spot in the
secretome (Fig. 7B). If protein spots in the secretome were
simply the result of cell lysis, not only should their relative
position on the gel be the same between the cytosol and
the secretome, but the ratio of the proteins to each other
in each subproteome should be the same in both. The
results show that two thirds of all protein spot positions
as well as relative abundances are distinctively different
between the cytosol and secretome. Therefore, cell lysis
can be excluded as the major contributor to the protein
accumulation in the secretome. The extracellular proteins
were further analyzed using various bioinformatics soft-
ware programs, such as SignalP, SecretomeP, PSORT,
LipoP, TMHMM, and PROSITE for predicting protein
secretion and localization.
Classical Sec pathway
A total of 53 proteins were predicted by SignalP to be
secreted in the classical Sec pathway, which is character-
ized by the presence of a signal peptide [16,17] (addi-
tional file 1). Of the 53 proteins containing the signal
peptides, 38 proteins have the cleavage site for signal
peptidase I (SpI). These proteins are predicted to be
secreted into the external environment, because they lack
additional retention signals. However, 10 proteins have
the cleavage site for signal peptidase II (SpII) and the
retention signals for lipid anchors while three proteins
were predicted to have transmembrane helices (TMH).
These proteins are predicted to have an extracytoplasmic
but cell-associated location. LipoP predictions discrimi-
nate between lipoprotein signal peptides, other signal
peptides, and N-terminal membrane helices with 93%
accuracy in Gram positive bacteria [18]. In contrast to
LipoP, TMHMM predicted 25 integral membrane proteins
with one to ten transmembrane helices [19] (additional
file 1). TMHMM predicts transmembrane protein topol-
ogy with a hidden Markov model with a 98% accuracy.
Additional predictions using PROSITE identified several
secreted proteins that are also know to be associated with
the bacterial cell wall by S-layer homology domains or
lipoprotein lipid attachment sites [7,20]. No cell wall
associated proteins with LPXTG-motifs were found in the
secretome. Despite its name, the LPXTG-motif cell wall
anchor domain protein does not contain such a domain.
In fact, it contains a NEAT domain that might be involved
in the transport of iron.
Alternative Sec pathway
Twenty-three proteins were predicted by SecretomeP to be
secreted by the non-classical Sec Pathway characterized by
the lack of typical export signals [21]. In contrast to the
predictions of SignalP and SecretomeP, PSORT [22] pre-
dicted 171 extracellular proteins, 7 cell wall-associated
proteins, and 6 cytoplasmic proteins. Using the whole
genome of B. anthracis, Binnewies et al. have calculated
that the Bacillus anthracis Ames strain has 6% secreted pro-
teins predicted using SecretomeP, 3% using LipoP, and
6% using SignalP [23].
Immunogenic extracellular proteins
The main immunogenic proteins detected by 2-DE West-
ern blot analysis using sera from humans infected with
cutaneous anthrax include the 83 and 63 kDa charge var-
iants of protective antigen (PA), followed by charge vari-
ants of enolase and transketolase (Fig. 2D). The protective
antigen produced in vivo has a molecular mass of 83 kDa
(A) 2-DE gel image of SYPRO Ruby-stained cytosol proteins  of toxigenic, non-encapsulated B. anthracis strain RA3R  (pXO1+/pXO2-) from pH 4 to 7 at 16 hr under induced con- ditions Figure 7
(A) 2-DE gel image of SYPRO Ruby-stained cytosol proteins 
of toxigenic, non-encapsulated B. anthracis strain RA3R 
(pXO1+/pXO2-) from pH 4 to 7 at 16 hr under induced con-
ditions. (B) 2D Phoretix comparative analysis of the cytosol 
with the secretome at 16 hr under induced conditions. Pro-
teins encircled in red are more than two fold up-regulated, 
proteins encircled in yellow are more than two fold down-
regulated, proteins encircled in green are between these lim-
its, and proteins encircled in blue are unmatched between 
the two sub proteomes.Proteome Science 2007, 5:11 http://www.proteomesci.com/content/5/1/11
Page 6 of 10
(page number not for citation purposes)
and is subsequently cleaved by cell-associated protease
activity resulting in a 63 kDa protein that binds the lethal
factor to form lethal toxin [24]. Notably, 17 charge and
mass variants of PA were detected. These include five
charge variants of the 83 kDa PA isoforms, seven charge
variants of the 63 kDa PA isoforms and five charge vari-
ants of the 37 kDa PA isoforms. Charge variants of PA
have been reported previously. Their generation was due
to the spontaneous deamidation of asparagine residues
which is dependent on pH, temperature, primary
sequence ("nearest neighbor" effect) and protein confor-
mation [25]. Charge variants of enolase and transketolase
were also noted. Enolase has also been reported previ-
ously as component of the B. anthracis spore [26] and as
one of the immunodominant spore antigens [27]. Other
minor immunogenic proteins were also detected by 2-DE
Western blot analysis but were not identified.
Discussion
The secretome of B. anthracis has been the subject of
recent proteomic studies [6-9]. Interest in its study comes
from the fact that several secreted proteins of B. anthracis
are known virulence factors (e.g., PA, EF, LF). Other
secreted proteins may potentially be involved in the
adherence of the bacteria to host cells while some may be
required for the suppression of the host's defense mecha-
nisms. While several of the virulence proteins have been
identified by recent proteomic studies [6,7], the time
course of protein secretion by a toxigenic but non-encap-
sulated strain RA3R (pXO1+/pXO2-) under host simulated
conditions has not been reported. In this study, the
dynamics of secretion of several proteins were investi-
gated at different time points during the exponential
growth phase of B. anthracis. The same collection points
have been used previously by Lamonica et al. [9] for the
isolation of secretome proteins. Chitlaru et al. [6] and
Antelmann et al. [7] isolated secretome proteins at analo-
gous growth stages as well. As shown in Fig. 5, the rate of
protein secretion varies for each protein. It should be
noted that at 6 hours, PA has the highest rate of secretion
of all secreted proteins. Since PA is a major component of
the anthrax toxin, its high secretion rate at this early time
point confirms the critical role this protein plays during
the onset of anthrax pathogenesis. Two other proteins that
were detected in high abundance in the culture superna-
tant are the S-layer proteins, EA1 and Sap, both of which
are components of the cell wall. Both proteins contain a
signal peptide followed by three SLH (S-layer homology)
anchoring domains and are considered major surface
antigens. The amount of these two proteins was highest at
the 16-hour time point compared to the other identified
extracellular proteins. It has been previously described
that Sap is sequentially replaced by EA1 [28]. This rapid S-
layer turnover results in the release and spillover of these
proteins into the secretome.
Several of the secretome proteins have metabolic func-
tions that would typically place them in the cytoplasm.
This is similar to the results by Antelmann et al. [7] in
which more than half of the identified secretome proteins
were associated with the cell wall or cytosol. We also iden-
tified 25 proteins that were predicted to have transmem-
brane helices which would typically associate them to the
cell wall. All but one of these proteins were predicted to be
secreted by SignalP or SecretomeP and half of these pro-
teins have also been identified before as a natural compo-
nent of the secretome (see additional file 1).
Extracellular accumulation of B. anthracis proteins
Combined analysis using SignalP and SecretomeP of the
B. anthracis secreted proteins indicated that 28% of the
detected proteins are extracellular whereas 62% are pre-
dicted to be extracellular using PSORT. The remaining
proteins were predicted to be cytoplasmic since they
lacked known export signals or are cell-associated because
they have membrane-anchoring or cell wall retention sig-
nals. Using LipoP, some of the proteins are predicted to be
bound at the trans surface of the cytoplasmic membrane.
Contrary to their predicted location, a number of proteins
with retention signals for covalent or non-covalent attach-
ment to the cell walls were also found in the extracellular
environment.
While bioinformatics tools are useful for predicting cellu-
lar function and localization, considerable variation exists
in the number of proteins that were predicted to be extra-
cellular, cytoplasmic, or membrane bound. This is
expected because each of these bioinformatics tools uses
different algorithms and assumptions in their predictions.
Further empirical studies are therefore required to verify
the precise location of proteins for which conflicting pre-
dictions are noted.
Immunogenic extracellular proteins
The use of sera from human patients infected with cutane-
ous anthrax confirmed the high immunogenicity of PA in
the secreted proteins of the toxigenic but non-encapsu-
lated B. anthracis strain RA3R (pXO1+/pXO2-). Although
several mass and charge variants of PA were detected, the
most immunogenic are the 63 and 83 kDa charge variants.
In addition to PA, the major component of AVA (anthrax
vaccine adsorbed), enolase and transketolase were found
to be highly immunogenic. AVA is an alum precipitate
prepared from B. anthracis culture filtrates and is a
licensed vaccine currently used to protect humans against
anthrax. Enolase was also described previously as part of
the AVA culture filtrate [29]. AVA preparations contain
contaminating proteins whose benefits are not known,
but the presence of the highly immunogenic enolase in
this formulation might contribute to its protective immu-
nity over a vaccine containing just PA. The membrane pro-Proteome Science 2007, 5:11 http://www.proteomesci.com/content/5/1/11
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teins Sap and EA1 were also found in the secretome by
Chitlaru et al. [6] and Antelmann et al. [7] as the most
abundant extracellular cell wall proteins. Both proteins
were reported as major surface antigens and potential vac-
cine carriers in vivo [30,31]. EA1 and Sap are also major
components of AVA [29] and are associated with a variety
of functions ranging from evasion of host recognition, cell
adhesion and resistance, and phagocytosis [1,32,33].
Interestingly no reactivity to these proteins was observed
using sera from patients with subcutaneous anthrax infec-
tion. Overall fewer immunogenic proteins were detected
using human sera from patients infected with cutaneous
anthrax than in a recent study by Chitlaru et al. [30] who
used experimentally challenged rabbit and guinea pig
sera. There is a quantitative and qualitative difference
between sera from recovering humans and sera from mul-
tiple challenged animals. Since with human sera enolase
and transketolase were major immunogens beside PA,
they might be promising candidates for next generation
anthrax subunit vaccines besides the newly identified pro-
teins using animal sera [30].
Conclusion
The work presented here is the first description of the time
course of protein secretion for B. anthracis grown under
host-simulated conditions. The combined use of two
types of mass spectroscopy led to the identification of 275
proteins and their secretion patterns during the exponen-
tial growth phase of B. anthracis. While the secretome con-
tained several predictable proteins (e.g. PA, LF, Sap, and
EA1) many proteins were identified which would not be
expected in the secretome such as proteins involved in
energy metabolism and protein translation. The discovery
of proteins in the secretome that are traditionally thought
to be strictly cytosolic has often been assumed to result
from contamination. However, this may not be true since
cytosolic proteins, such as aldolase, enolase, elongation
factor G, and various dehydrogenases, have also been
detected in the secretome of group A streptococci [34],
mycobacteria [35,36], and B. subtilis [37]. Some proteins
may be cytoplasmic at one point of the cell cycle and
secreted via pathways which are yet to be understood dur-
ing other stages of the cell cycle. While prediction software
are a good tool to characterize a large group of proteins,
different algorithms give diverging results. It is far more
difficult to accurately predict a precise location within a
cell of non-classical secretory proteins than to recognize
proteins which are secreted by a signal peptide. The ulti-
mate proof is to empirically validate their results. This
study helps to bridge the gap between pure in silico predic-
tion and in vivo observation.
This study also identified the major immunoreactive pro-
teins of the B. anthracis secretome using 2-DE Western
blot analysis from humans infected with the pathogen.
These proteins included the expected PA as well as enolase
and transkelolase. The immunoreactive secretome pro-
teins contribute to the list of other B. anthracis immuno-
genic proteins that were idenfied in other subproteomes
or life-stages of the infectious agent. This knowledge will
ultimately lead to the development of a more-specific,
safer, and highly efficacious vaccine against B. anthracis. In
addition, the identification of early high abundance secre-
tome proteins may aid in the development of detection
and diagnostic kits for those cases, where the direct cap-
ture of the pathogen is not possible.
Methods
Bacterial strain and culture conditions
An attenuated derivative strain of B. anthracis, RA3R
(pXO1+/pXO2-), was used. A loop was streaked on BHI
agar overnight (16 hr) at 37°C. A single colony was trans-
ferred to 2 ml R medium [4] and approximately 1 ml of
the resulting suspension was immediately transferred in
100 ml R medium supplemented with 0.25% [wt/vol]
glucose. The flask was mixed gently and fitted with a Bug-
Stopper (Whatman Inc., Clifton, NJ) sterile venting clo-
sure. The culture was incubated at 37°C with shaking at
120 rpm for 5 to 6 hr. Following this growth period, 5 ml
of the culture was transferred to a 250-ml sterile, vented,
canted Falcon tissue culture flask containing 70 ml R
medium with 0.25% [wt/vol] glucose and 0.85% [wt/vol]
sodium bicarbonate. The composition of the R-medium
in mg/l is: L-tryptophan, 35; glycine, 65; L-cystine, 25; L-
tyrosine, 144; L-lysine, 230; L-valine, 173; L-leucine, 230;
L-isoleucine, 170; L-threonine, 120; L-methionine, 73; L-
aspartic acid, 184; sodium L-glutamate, 612; L-proline,
43; L-histidine-hydrochloride, 55; L-arginine-hydrochlo-
ride, 125; L-phenylalanine, 125; L-serine, 235; thiamine-
hydrochloride, 1.0; CaCl2 2H20, 7.4; MgSO4 H20, 9.9;
MnSO4 H20, 0.9; K2HPO4, 3,000; uracil, 1.4; and adenine
sulfate, 2.1, pH 8.0. The culture was grown for 6 to 16 hr
at 37°C under 5% CO2 in a humid incubator according to
Ristroph et al. [4] to simulate conditions encountered in
the host. The pH at the end of the incubation period rises
to pH 8.15. During this time the cells are in the exponen-
tial growth phase, between lag- and stationary- phase.
Uninduced cultures were grown in R medium without the
addition of sodium bicarbonate and without CO2 supple-
mentation.
Preparation of extracellular protein fraction
Culture filtrates (secretomes) were collected at 6 hr (early
log phase), 10 hr (mid log phase), and 16 hr (late log
phase) time points based on the growth curve for B.
anthracis in R medium, as determined by OD595 readings.
The culture filtrates were centrifuged for 10 min and the
supernatant containing the extracellular proteins was
passed through a 0.45-µm filter to remove any suspended
vegetative cells. The culture filtrates were concentratedProteome Science 2007, 5:11 http://www.proteomesci.com/content/5/1/11
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using Jumbosep, Macrosep, and Microsep filters with a 10
kDa cutoff (Pall Inc., East Hills, NY). Ice-cold trichloroace-
tic acid (TCA; Sigma Chemical Co., St. Louis, MO) was
then added to a final concentration of 10% TCA (vol/vol),
chilled on ice for 45 min, and then centrifuged for 45 min.
The resultant pellet was washed with 3 ml acetone and
centrifuged. The pellet containing the secretome proteins
was resuspended in 100 µl of 7 M urea, 2 M thiourea, 1%
3-(4-heptyl)phenyl-3-hydroxypropyl-dimethylammonio-
propanesulfonate, and 40 mM Tris prior to IEF. The pro-
tein concentration of the extracellular protein extract was
determined using the Bio-Rad Protein Assay kit (Bio-Rad
Laboratories, Hercules, CA). Bovine serum albumin was
used as the standard for determination of protein concen-
tration.
2-DE and Western blot analysis
2-DE was carried out with the ElectrophoretIQ3 system
and following the manufacturer's protocols (Proteome
Systems, Woburn, MA). One-hundred µg of proteins were
separated by IEF on 11 cm (pH 4 to 7) linear IPG strips.
After 12 hr rehydration, the following focusing parame-
ters were applied: 50 µA per strip, linear voltage increase
over 8 hr from 100 V to 10,000 V, and then held at 10,000
V for 10 hr. After IEF, IPG strips were equilibrated in equi-
libration buffer and applied onto a 6–15% gradient SDS-
PAGE. Gels were electrophoresed for 1.5 hr at 500 V and
stained with Sypro Ruby (Sigma-Aldrich, St. Louis, MO)
for gel analysis or with ProteomIQ Blue (Proteome Sys-
tems) for MALDI-TOF MS analysis. Four replicate 2-DE
gels of each sample were used for computer analysis using
Phoretix 2D Expression software (Nonlinear Dynamics)
and MALDI-TOF MS. Following automatic spot detection
on quadruple gels using Phoretix 2D Expression's detec-
tion algorithm, gels were manually warped and their com-
mon spots were matched to generate average gels.
Immunoblotting was conducted according to Towbin et
al. [38]. Proteins on 2-DE gels were transferred to PVDF
membranes using Towbin buffer (0.025 M trisma base in
0.192 M glycine) with 20% methanol at 100 V for 30 min.
After transfer, the PVDF membrane was washed twice for
5 min each in 0.01% Tween-20 in PBS (PBST) and
blocked with 0.2% I-Block (Tropix, Bedford, MA) for 1 hr.
To identify immunogenic proteins, the PVDF membranes
were washed three times with PBST for 5 min and then
probed with a 1:1000 dilution of sera pooled from
patients who recovered from cutaneous anthrax. The
PVDF membrane was washed three times with PBST and
incubated with 1:5000 dilution of appropriate secondary
antibody. Chemiluminescent signals were visualized
using the Western Lightning reagents (Perkin-Elmer,
Wellesley, MA). Corresponding sera from uninfected
humans were used as controls (Cambrex, Charles City,
IA). Three replicate blots were used for computer analysis
using the Phoretix 2D Expression software to identify the
immunogenic proteins.
In-gel trypsin digestion and MALDI-TOF MS
Protein spots were excised, washed, and trypsin digested
from 2-DE gels according to manufacturer's instructions
using the Xcise robotic workstation (Shimadzu Biotech,
Columbia, MD). Briefly, gel plugs were washed with 50
mM ammonium bicarbonate and 50% acetonitrile
(ACN), dried, and treated with 1.6 µg/ml of trypsin in 50
mM ammonium bicarbonate at 37°C overnight. Tryptic
peptides were applied to a MALDI-TOF MS plate in a solu-
tion of 10 mg/ml alpha-cyano-4-hydroxycinnamic acid in
0.1% trifluoroacetic acid and 50% ACN. MS spectra were
obtained using an Axima-CFR plus (Shimadzu Biotech) in
a positive ion reflectron mode and analyzed against the
theoretical spectra of B. anthracis strain Ames, using the
Mascot Daemon software package (Matrix Science, Bos-
ton, MA). The search parameters were: maximum of one
missed cleavage by trypsin, fixed modification of oxida-
tion, charged state of + 1, and mass tolerance of ± 0.5 Da.
Protein identification by LC MS/MS
All LC MS/MS analyses were performed using an Agilent
1100 nanopump system coupled with a Vydac C18
reverse phase column (75 µM) (Agilent, Santa Clara, CA)
and a QTRAP 2000 LC MS/MS system (Applied Biosys-
tems, Foster City, CA) outfitted with a nanospray source
and controlled with Analyst 1.4.1 software. Proteins were
prepared for digestion using heat denaturation and a
modified organic-aqueous digestion method as described
before [14]. Each digested and desalted sample was re-sus-
pended in 10 µl of Buffer A (95% water, 5% ACN, 0.1%
formic acid). Each sample (7 µl) was loaded onto the LC
MS/MS system and analyzed using an independent data
acquisition method with the following parameters: single
enhanced mass spectra (EMS, 500–1500 m/z) from which
the three most intense peaks were subjected to an
enhanced resolution, from which ions with a charge state
of + 2 to + 4 were subjected to an enhanced product ion
[EPI (MS/MS)] scan. Once the three most intense peaks
were subjected to downstream analysis, they were ignored
for a period of 60 sec. LC gradient was 5–60% Buffer B
(95% ACN, 5% water, 0.1% formic acid) over 35 min.
General parameter settings are as follows (curtain gas:
15.00, collision gas: High, ion spray: 2200 v, interface
heater: on, declustering potential: 30, entrance potential:
10, collision energy: 10, rolling collision energy). All MS/
MS data were searched against the theoretical spectra of B.
anthracis Ames using the MASCOT software (Matrix Sci-
ence). The search parameters used were: maximum of one
missed cleavage by trypsin, fixed modification of oxidized
methionine, charge state of + 2 and + 3, an MS tolerance
of ± 1.2 Da and an MS/MS tolerance of ± 0.8 Da. OnlyProteome Science 2007, 5:11 http://www.proteomesci.com/content/5/1/11
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protein identifications that met or exceeded the minimal
MOWSE score of 22 were included in additional file 1.
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